Innovus Pharmaceuticals (INNV): Price and Financial Metrics

Innovus Pharmaceuticals (INNV): $14.00

0.15 (+1.08%)

POWR Rating

Component Grades













INNV Stock Price Chart Interactive Chart >

Price chart for INNV

INNV Price/Volume Stats

Current price $14.00 52-week high $27.18
Prev. close $13.85 52-week low $13.59
Day low $13.59 Volume 278,700
Day high $14.23 Avg. volume 272,955
50-day MA $16.21 Dividend yield N/A
200-day MA $0.00 Market Cap 1.90B

Innovus Pharmaceuticals (INNV) Company Bio

Innovus Pharmaceuticals is an over-the-counter (OTC) consumer goods and pharmaceutical company engaged in the commercialization, licensing and development of safe and non-prescription medicine, consumer care products, supplements and medical devices to improve men's and women's health and vitality. Co.'s products focuses on six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. Co. delivers health solutions of OTC medicines, devices, consumer and health products, and clinical supplements through four general channels including Direct to Consumer Marketing, E-Commerce, Retail/Wholesale, and International Distribution.

INNV Latest News Stream

Event/Time News Detail
Loading, please wait...

INNV Latest Social Stream

Loading social stream, please wait...

View Full INNV Social Stream

Latest INNV News From Around the Web

Below are the latest news stories about InnovAge Holding Corp that investors may wish to consider to help them evaluate INNV as an investment opportunity.

InnovAge to Announce Fiscal Fourth Quarter 2021 Financial Results and Host Conference Call Tuesday, September 21, 2021

DENVER, Aug. 31, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) will release its 2021 fiscal fourth quarter and year-end financial results on Tuesday, September 21, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsThe conference call can be accessed by dialing (833) 398-1024 for U.S. participants, or (914) 987-7722 for international participants, and referenc

Yahoo | August 31, 2021

InnovAge PACE Centers in Virginia and New Mexico Recognized for Quality of Patient Care

Virginia Centers Join Centers in Three Other States in Achieving Certification by the National Committee for Quality AssuranceDENVER, Aug. 20, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) today announced that its four Program of All-inclusive Care for the Elderly (PACE) centers in Virginia have been certified as Patient-Centered Medical Homes (PCMH) by the National Committee for Quality Assurance (NCQA). The centers, located in Charlottesville, New

Yahoo | August 20, 2021

InnovAge Makes Equity Investment in Jetdoc, Partnering to Develop PACE-Specific Telehealth and Remote Patient Monitoring Platform

DENVER, Aug. 04, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) today announced that it has made an equity investment in telehealth platform Jetdoc, a telehealth and virtual urgent care app dedicated to connecting users with medical professionals in an effective way. InnovAge’s investment comes amid continuing demand for virtual healthcare services across healthcare sectors. As of July 2021, telehealth utilization had stabilized at 38 times higher than pre-pandemic l

Yahoo | August 4, 2021

InnovAge Pennsylvania LIFE Centers Recognized for Quality of Patient Care

Certification by National Committee for Quality Assurance Reinforces InnovAge's Continued Commitment to Delivering Patient-centered Senior HealthcareDENVER, July 26, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) today announced that three of its LIFE centers in Pennsylvania have been certified as Patient-Centered Medical Homes (PCMH) by the National Committee for Quality Assurance (NCQA). The Company’s Allegheny, Germantown and St. Bart’s centers we

Yahoo | July 26, 2021

Here is What Hedge Funds Think About InnovAge Holding Corp. (INNV)

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]

Yahoo | July 6, 2021

Read More 'INNV' Stories Here

INNV Price Returns

1-mo -5.91%
3-mo -38.49%
6-mo -41.67%
1-year N/A
3-year 10.19%
5-year -56.08%
2020 0.00%
2019 -87.41%
2018 -19.40%
2017 -57.93%
2016 183.57%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8576 seconds.